Assignee
AUTOTELIC LLC
US·7 granted patents·16 pending applications·4 citations·filing 2014–2017
Top patents by PatentIndex Score
23 records- 0185US9758786B2Compositions and methods for treating pancreatic cancerAUTOTELIC LLC·Filed 2016·Granted Sep 12, 2017·2 cites·7 claims
- 0278US9763892B2Immediate release phospholipid-coated therapeutic agent nanoparticles and related methodsAUTOTELIC LLC·Filed 2016·Granted Sep 19, 2017·1 cites·30 claims
- 0372US9678078B2Methods and compositions for personalized medicine by point-of-care devices for brain natriuretic peptideAUTOTELIC LLC·Filed 2014·Granted Jun 13, 2017·1 cites·1 claims
- 0467US2017035787A1Fixed Dose Combination for Pain Relief Without EdemaAUTOTELIC LLC·Filed 2016·Application pending·0 cites
- 0567US2017071956A1Fixed Dose Combination for Pain Relief Without EdemaAUTOTELIC LLC·Filed 2016·Application pending·0 cites
- 0664US2016008371A1Fixed dose combination for pain relief without edemaAUTOTELIC LLC·Filed 2015·Application pending·0 cites
- 0764US2016022639A1Fixed dose combination for pain relief without edemaAUTOTELIC LLC·Filed 2015·Application pending·0 cites
- 0861US9963703B2Compositions and methods for treating pancreatic cancerAUTOTELIC LLC·Filed 2017·Granted May 8, 2018·0 cites·11 claims
- 0961US2017202861A1Celocoxib Binding Antibodies and Uses ThereofAUTOTELIC LLC·Filed 2017·Application pending·0 cites
- 1058US2018074063A1Methods and Compositions for Personalized Medicine by Point-of-Care Devices for FSH, LH, HCG and BNPAUTOTELIC LLC·Filed 2017·Application pending·0 cites
- 1158US2017276680A1Methods and compositions for personalized medicine by point-of-care devices for brain natriuretic peptideAUTOTELIC LLC·Filed 2017·Application pending·0 cites
- 1256US2017312347A1Methods For Treating Cancers Using Ace Inhibitors, ARB, or Celecoxib and OlmesartanAUTOTELIC LLC·Filed 2017·Application pending·0 cites
- 1356US2017326109A1Fixed Dose Combination for Pain Relief Without EdemaAUTOTELIC LLC·Filed 2017·Application pending·0 cites
- 1456US2018153818A1Phospholipid-coated therapeutic agent nanoparticles and related methodsAUTOTELIC LLC·Filed 2017·Application pending·0 cites
- 1552US9989543B2Composition, device, and method for detecting olmesartan and improving compliance in treating hypertensionAUTOTELIC LLC·Filed 2017·Granted Jun 5, 2018·0 cites·12 claims
- 1644US2018136242A1Methods, devices, and reagents for monitoring paclitaxel concentration in plasma for pharmacokinetic-guided dosing of paclitaxelAUTOTELIC LLC·Filed 2017·Application pending·0 cites
- 1742US2016120885A1Fixed dose combination for pain relief without edemaAUTOTELIC LLC·Filed 2016·Application pending·0 cites
- 1840US9714953B2Methods, devices, and reagents for monitoring paclitaxel concentration in plasma for pharmacokinetic-guided dosing of paclitaxelAUTOTELIC LLC·Filed 2015·Granted Jul 25, 2017·0 cites·15 claims
- 1940US2017226518A1Compositions and methods for treating cancerAUTOTELIC LLC·Filed 2016·Application pending·0 cites
- 2040US2016199392A1Method for individualized drug therapyAUTOTELIC LLC·Filed 2015·Application pending·0 cites
- 2138US2018221289A1Phospholipid-cholesteryl ester nanoformulations and related methodsAUTOTELIC LLC·Filed 2016·Application pending·0 cites
- 2237US2016199354A1Methods for olmesartan dosing by aucAUTOTELIC LLC·Filed 2016·Application pending·0 cites
- 2333US9964551B2Antibody-based affinity reagents for binding paclitaxelAUTOTELIC LLC·Filed 2016·Granted May 8, 2018·0 cites·13 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →